Enlivex Ltd. · NASDAQ:ENLV
Enlivex — Investor Presentation (November 2025)
24 slides from Enlivex's investor presentation, November 2025
Slide 1: RAIN Treasury Strategy
RAIN Treasury Strategy ENLIVEX ©
Slide 2: Forward-looking statements
Forward-looking statements This presentation contains forward-looking statements that are subject to various risks and uncertainties. Such statements include statements regarding the expected growth in the prediction markets industry, the ability to grow the business, the future use and market cap o
Slide 3: Executive Summary
Executive Summary Prediction markets are experiencing exponential Unique financial value proposition. ENLV obtained an growth, and are expected to mature into a highly exclusive option to acquire up to $918 million of RAIN, profitable, differentiated sector. expiration Nov 30, 2026, at price per RAI
Slide 4: Prediction Markets: How People Collectively Forecast the Future
Prediction Markets: How People Collectively Forecast the Future ● A prediction market is a platform that facilitates the trading of contracts whose value depends on the outcome of future events. ● Participants buy and sell shares tied to different possible results, allowing the market as a whole to
Slide 5: The Explosive Growth of Prediction Markets
The Explosive Growth of Prediction Markets Metric An emerging challenger with a Permissioned, crypto-native US-regulated, centralized Platform Type lot of potential to break into that prediction market on Polygon. platform for event contracts. top tier Cumulative Trading $22.692 billion $15.905 bill
Slide 6: Institutional Backing of Prediction Markets
Institutional Backing of Prediction Markets $2BN investment ($8BN valuation) of Kalshi’s $300MM financing ($5BN Intercontinental Exchange (ICE), the parent valuation) led by Andreessen Horowitz and company of the New York Stock Sequoia Exchange (NYSE) in Polymarket 6|
Slide 7: Centralized prediction markets face challenges
YET, Centralized prediction markets face challenges //01 //02 //03 Regulatory restrictions Centralized Market Barriers Centralized liquidity KYC, licensing, and geo-blocks Users can’t freely launch markets, Markets stall without exclude many users. and outcomes often lack counterparties. transparenc
Slide 8: The Macro Opportunity: The Explosive Growth of Decentralized exchanges
The Macro Opportunity: The Explosive Growth of Decentralized exchanges We believe that DEX volume will outgrow centralized exchange (CEX) volume Metric MEV-free, one-click trading with up to 1001x The largest decentralized DEX, A DEX built with custom ZK infrastructure, High-speed perpetuals DEX bui
Slide 9: RAIN is a fully decentralized predictions and options protocol built on Arbitrum
RAIN is a fully decentralized predictions and options protocol built on the Arbitrum network. • The protocol is fully permissionless, allowing anyone to create and trade custom predictions on any market. • It is a protocol where anyone, from anywhere, can create any type of market, whether it's publ
Slide 10: The Uniswap of prediction markets: the concept
THE RAIN OPPORTUNITY The Uniswap of prediction markets: the concept Implementing the concept of a DEX Users swap directly with one another - no exchange, no Into Prediction Markets intermediaries, no Instead of trading currencies, gatekeepers. you’re trading outcomes. each with its own secondary Wit
Slide 11: The Uniswap of prediction markets: Borderless & user-friendly
THE RAIN OPPORTUNITY The Uniswap of prediction markets: Borderless & user-friendly Built on Arbitrum, providing a trustless The protocol is permissionless, and decentralized foundation. enabling anyone to create and trade custom options. Fully automated through smart Public market outcomes are AI- c
Slide 12: The Missing Link of Prediction Markets
The Missing Link of Prediction Markets Metric Language English English Any language Market Creation Disabled Disabled Anyone can create Liquidity Model Order-book matching & centralized liquidity Institutional and order book–based AMM-style liquidity provision Market type Public Public Public & Priv
Slide 13: Rain Protocol Applies a 5% Fee on the Total Volume of Each Market
Rain Protocol Applies a 5% Fee on the Total Volume of Each Market 2.5% for Participation Rewards 2.5% for Buyback and Burn This portion rewards key market participants: • The remaining half of the fee is used to buy back $RAIN tokens from the open market • 1.2% to the Market Creator and permanently
Slide 14: Enlivex aims to become the largest corporate holder of RAIN
Enlivex aims to drive shareholder value by becoming the largest corporate holder of RAIN and activating it for yield. Enlivex will accelerate institutional adoption of RAIN as it becomes at the center of global prediction markets. 14 |
Slide 15: Potential Yield Advantage of the Enlivex Treasury Strategy
Potential Yield Advantage of the Enlivex Treasury Strategy Enlivex seeks to outperform spot RAIN by capturing the full yield from staking and other sources. • Planend utilization of Full staking, restaking upon availability and selective DeFi, seeking to generate superior RAIN yield per unit of risk
Slide 16: Enlivex: Unique Financial Structure Advantage
Enlivex: Unique Financial Structure Advantage Enlivex, through its strategic partnership with the RAIN Foundation, obtained a mechanism to ensure low blended cost of capital to enhance RAIN concentration A unique financial value proposition. ENLV obtained an exclusive option to acquire up to $918 mi
Slide 17: Enlivex treasury team
Enlivex treasury team Matteo Renzi Board Member, Enlivex Amit Levin Elli Köstinger Advisor Advisor Former Prime Minister of Italy Former Global Investigator in Entrepreneur, Supervisory Board Binance’s Sanctions Member & Investor. Former Department. advises on Federal Minister of the Republic Matteo
Slide 18: Conclusion
CONCLUSION Prediction markets are expected to mature into a legitimate asset class. RAIN provides direct exposure to this emerging sector. RAIN stands out compared to other players in the sector. Deflationary token economics strengthen the DAT strategy. Enlivex is expected to be the world’s first an
Slide 19: Enlivex clinical development
Enlivex clinical development November 2025 Nasdaq: ENLV
Slide 20: Allocetra: An Off the Shelf Cell Therapy Designed to Restore Macrophage Homeostasis
ALLOCETRA : AN OFF THE SHELF CELL THERAPY DESIGNED TO RESTORE MACROPHAGE HOMEOSTASIS Process: A A PtdSer A Eat A A A A me Apoptotic cell collect cells from proprietary cells express cells are off the shelf, healthy donors apoptotic cell “eat me” signal frozen cost effective cell modification process
Slide 21: Allocetra Pipeline: Building Momentum
TM ALLOCETRA PIPELINE: BUILDING MOMENTUM Indication Study # Administration Pre-clinical Phase I/II Phase II Phase III Moderate to severe Local knee Randomized/controlled, Expected initiation ENX-CL-05-001 injection knee osteoarthritis NCT06233474 149 patients, enrollment completed Q2 2026 Temporoman
Slide 22: Trending with age
CLINICALLY MEANINGFUL, STATISTICALLY SIGNIFICANT POSITIVE EFFECT, HIGHLY CORRELATED WITH PRIMARY OA AGE THRESHOLD The positive effect of AllocetraTM on pain & function is substantial, with at least 6-month durability Change from baseline - 3 months Change from baseline - 6 months Trending with age A
Slide 23: Clinical Data Summary: 3 and 6-Month Topline Data – ENX-CL-05-001
CLINICAL DATA SUMMARY: 3 AND 6-MONTH TOPLINE DATA – ENX-CL-05-001 • Study objectives met • AllocetraTM demonstrated an encouraging safety profile, no related serious adverse events were reported • In primary age-related osteoarthritis patients, AllocetraTM treatment resulted in substantial, clinical
Slide 24: Opportunity Summary, Clinical Development
OPPORTUNITY SUMMARY, CLINICAL DEVELOPMENT Management team with a track record of creating shareholder value and getting drug products through marketing approvals globally in multi-billion dollar market segments Cost-effective, novel therapeutic modality with strong IP protection Targeted at high and